We warned that there was proof that the Pfizer BNT162b2 mRNA COVID vaccine caused heart damage in teens and young adults, as early as May of 2021.
As more information surfaces from the court-mandated release of Pfizer clinical trial documents by the FDA, and via FOIA’d emails, the CDC’s cover-up of evidence of COVID-19 mRNA vaccine-associated myocarditis in minors, becomes increasingly serious. Myocarditis is inflammation of the myocardium, resulting in tissue degeneration or necrosis.
For example, during the same time period that the Centers for Disease Control and Prevention (CDC) was repeatedly advising parents to get their children vaccinated against COVID-19, Pfizer was secretly testing for markers of heart damage in vaccinated kids. They looked for Troponin I in minors. When heart damage occurs, troponin I, a protein, gets released into the bloodstream.
While the CDC was urging parents to vaccinate their kids, Pfizer was studying how badly its mRNA COVID vaccine damaged children’s hearts.
Pfizer ran a study called ‘Phase 2/3 Obtaining Serum Samples for Potential Troponin I Testing.’ The study, which started in September 2021, was “…carried out in 2 age groups in order to collect blood samples for potential troponin I testing. The younger age group (5 to <12 years of age) will be placebo-controlled meaning you will receive either active vaccine or placebo. The older age group (12 to <16 years of age) will be open-label meaning everyone will receive active vaccine.”
Shortly after the initial release of Pfizer documents, in April 2022 I wrote my first report, which presented compelling evidence that Pfizer and the Food and Drug Administration (FDA) were both aware of the myocarditis-causing potential of the emergency use authorization (EUA) mRNA COVID vaccine. Subsequent research by the late German pathologist Dr. Arne Burkhardt [confirmed that myocarditis was caused by the mRNA injection?]: he revealed the presence of spike protein in the myocardium of autopsied patients who had ‘died suddenly,’ as well as revealing scarring as a result of autoimmune effects.
Who Knew What, and When?
It became clear by February 2021 that a myocarditis safety signal was in the data and in scientific research ‘in press’ – meaning, scientific research which had passed peer review and been accepted for publication but that was not in print. In fact, the Israeli Ministry of Health alerted the CDC to a myocarditis safety signal on February 28, 2021.
My previously mentioned ‘Report 11: Pfizer Vaccine – FDA Fails to Mention Risk of Heart Damage in Teens‘ clarified that the committees reviewing the vaccine rollout had received information from the Pfizer Post-Marketing Experience 5.3.6 document, released in full in Spring 2021, and from other publicly available information that showed 35 cases of myocarditis in children within one week after receiving the second dose of the Pfizer mRNA vaccine.
In April 2021, Israel began examining an unexpected incidence of myocarditis primarily linked to the second dose of the mRNA COVID vaccine.[https://www.reuters.com/world/middle-east/israel-examining-heart-inflammation-cases-people-who-received-pfizer-covid-shot-2021-04-25/] This finding was contrary to prevailing message at that time that COVID infection caused myocarditis. In June 2021, Israel reported a link between a second shot of the Pfizer mRNA COVID vaccine and heart problems in males under the age of 30.
Emails between the CDC and the White House, obtained through FOIA by Ed Berkovich and reported by Amy Kelly, show that the White House and other top health agencies were aware of this information, and sought to cover it up.
These emails reveal the panic within the White House and public health agencies, that unfolded even as the agencies directed consistent media promotion that the vaccine was “safe and effective.”
The FOIA-produced emails, despite being heavily redacted, contain revealing information. As Ms. Kelly reported, “Astonishingly, the emails reveal that the most senior leaders, up to the White House, knew about heart damage linked to mRNA vaccines yet colluded behind the scenes to conceal this side effect from the American people.” (For a comprehensive description and analysis of the FOIA’d emails, please refer to Amy Kelly’s article.)
As noted above, at first the public health agencies’ messaging – and thus the general fear – was that myocarditis might result from COVID-19 infection. This message prompted public health entities and medical professionals to advocate for COVID vaccination.
On May 23, 2021,Demetre Daskalakis, MD, COVID CDC Response Role: Senior Lead, Equity in COVID Data and Engagement and Director of CDC Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, sent a slide deck with the filename ‘Myocarditis update deck 5232021 Final’ to Henry Walke, MD, MPH, CDC Director of the Office of Readiness and Response (the FOIA’d version is almost completely redacted). This event prompted a flurry of also-mostly-redacted emails between CDC personnel and others.
Thus, the CDC knew by then that COVID vaccine-related myocarditis occurred, yet the agency worked hard publicly to minimize the seriousness of that risk, and to conceal that possible cause and effect.
What do the October 2023 Pfizer documents released by the FDA Reveal, Which Demonstrate U.S. Federal-Level Health Agencies’ Awareness of Vaccine-Induced Myocarditis?
Continue reading full story here: Report 94: Pfizer Secretly Studied a Heart Damage Marker, Troponin I, in Five- to 15-Year-Olds, Following mRNA COVID Vaccination in 2021. – DailyClout